The Crux of Medtech
Welcome to The Crux of Medtech, where we sit down with special guests from the medtech industry.We tell the stories of this incredible sector by looking inside businesses from across the trade.
- Indexed episodes, last 90 days
- 13
- Latest publication
- Sep 24, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 8, 2026
Latest episodes
Don't Use The D Word With Christian Howell (opens the original)
Read excerpt
In this episode of the Crux of Neuro, Liz Moyles is joined by Christian Howell, CEO of Cognito Therapeutics, to explore what happens when neuroscience, light, sound, and clinical research come together to tackle one of the biggest challenges in brain health: Alzheimer’s disease. From MIT research on 40Hz gamma activity to a home-based therapy using light and sound, Christian explains the science behind Cognito’s approach and what it takes to translate breakthrough neuroscience into something pat
Your Brain Is the Softest Thing in Your Body, that's Why All Implants Are Wrong with Dr. Nicolas Vachicouras (opens the original)
Read excerpt
In this episode of the Crux of Neuro, Liz Moyles sits down with Dr. Nicolas Vachicouras, PhD, CEO and Co-Founder of Neurosoft Bioelectronics, a Geneva and New York-based neurotechnology company spun out of EPFL, developing the world's softest, stretchable brain interfaces. Nicolas takes us through his journey from studying the bionic eye, to building brain interfaces for epilepsy, tetraplegics, and severe tinnitus and why the key to all of it starts with matching the mechanical properties of the
The Brain Knows How to Heal, Medicine Just Hasn't Caught Up with Dr. Leo Petrossian (opens the original)
Read excerpt
In this episode of Crux of Neuro, host Liz Moyles is joined by Dr. Leo Petrossian, CEO of Kandu, Inc. the company formed from the merger of Neurolutions and Kandu Health. Leo has spent over 20 years at the intersection of neurotech and clinical care, and under his leadership, Neurolutions secured FDA breakthrough clearance for the IpsiHand®: the first non-invasive, at-home brain-computer interface for stroke rehabilitation. He also navigated the first BCI-specific CMS billing code and led a rand
The Bravest Thing a CEO Can Say Is "I Don't Know" with Renee Ryan (opens the original)
Read excerpt
In this episode of the Crux of Neuro, Renee Ryan, co-founder and CEO of PinPrint and former CEO of Cala Health. Renee traces her path from Wall Street healthcare banker to one of medtech’s most prolific investors and operators. She explains why, in neurotech today, getting reimbursed is often harder than getting cleared and how data became the whole story. Key Topics Renee’s path from healthcare investment banking to leading J&J’s medtech investing (JJDC) Founding Verb Surgical and investing acr
The Tricuspid Valve Was Forgotten for Decades. TRiCares Is Changing That with Ahmed Elmouelhi (opens the original)
Read excerpt
In this episode, Jordan is joined by Ahmed Elmouelhi, President & CEO of TRiCares, the company behind Topaz, a purpose-built transcatheter tricuspid valve replacement system now in head-to-head pivotal trial against Edwards EVOQUE in the US. Ahmed brings over 20 years of structural heart experience, including nearly a decade building TAVR and LAA therapies at AtriCure and Medtronic, and explains exactly why he crossed to the right side of the heart and what it took to build a valve that doesn't
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.